Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Isabelle Ragueneau-Majlessi

Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions With Drugs Approved by the U.S. Food and Drug Administration in 2017

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2018English

Physiologically Based Pharmacokinetic (Pbpk) Model of the Cyp2d6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2017English

Related publications

Php343 - Clinical Development of Biologics Approved by the U.S. Food and Drug Administration, 2003-2016

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Bipolar Disorder: A Review of Current U.S. Food and Drug Administration Approved Pharmacotherapy

International Journal of Basic and Clinical Pharmacology
2015English

New Antimicrobial Agents Approved by the U.S. Food and Drug Administration in 1997 and New Indications for Previously Approved Agents

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

New Antimicrobial Agents Approved by the U.S. Food and Drug Administration in 2004 and New Indications for Previously Approved Agents

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

New Antimicrobial Agents Approved by the U.S. Food and Drug Administration in 2000 and New Indications for Previously Approved Agents

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2001English

New Antimicrobial Agents Approved by the U.S. Food and Drug Administration in 2010 and 2011 and New Indications for Previously Approved Agentsa

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Alterations of Chemotherapeutic Pharmacokinetic Profiles by Drug–drug Interactions

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2009English

Drug Development Process and Novel Drugs Approved by FDA for 2017 -18

Applied Clinical Research, Clinical Trials and Regulatory Affairs
2018English

Effects of Food and Drug Administration-Approved Medications for Alzheimer’s Disease on Clinical Progression

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy